ECRIN Integrating Activities call
ESE Careers portal - search for opportunities and upload your CV (2)

Prolia (Denosumab) approved for male osteoporosis (Medical News Today, 24 September 2012)

24 Sept 2012

The US Food and Drug Administration (FDA) has approved the marketing application for Amgen's Prolia (Denosumab) in the treatment of osteoporosis in men.

Full article

Related Topics

Adrenal Diabetes Metabolism Obesity Cardiovascular Bone Endocrine-Disrupting Chemicals Endocrine-Related Cancer Neuroendocrinology Reproduction Steroid and Steroidogenesis Thyroid

Share this story

Top stories

Call for nominations for Awards Committee Chair
30 Oct 2024

James M Tanner Award - 2025 nominations open
30 Oct 2024

Would you like to host the BSPED annual meeting?
21 Oct 2024

Most read